Literature DB >> 8773298

The role of alpha v-integrins in tumour progression and metastasis.

J F Marshall1, I R Hart.   

Abstract

Metastatic tumour spread is a pathologic process which can be described as altered cell growth associated with a series of adhesion/de-adhesion events which are coupled with regulated tissue degradation. Adhesion to, and migration through, the extracellular matrix (ECM) is necessary for the tumour invasion which is an important part of the metastatic process. Efficient proteolytic digestion of the molecules of the ECM appears to be facilitated by the localization of proteases at the cell surface-tissue interface (see also review by Stetler-Stevenson). Indeed, there is evidence from in-vitro studies to suggest that restriction of these enzymes to focal contact sites (areas of cell-substratum contact) may occur and that this sub-cellular juxtaposition of receptors and enzymes co-ordinates regulation of adhesion and proteolysis by the neoplastic cells. How such co-ordinated regulation is achieved and how this dynamic interplay is controlled during tumour development and progression are important areas of investigation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8773298     DOI: 10.1006/scbi.1996.0018

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  21 in total

1.  Role of integrin alpha(v)beta3 in the early phase of liver metastasis: PET and IVM analyses.

Authors:  Hironori Kikkawa; Masako Kaihou; Natsuko Horaguchi; Takayuki Uchida; Hidetoshi Imafuku; Ayano Takiguchi; Yukako Yamazaki; Chieko Koike; Ryoko Kuruto; Takeharu Kakiuchi; Hideo Tsukada; Yoshikazu Takada; Nariaki Matsuura; Naoto Oku
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

2.  beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.

Authors:  S Hapke; M Gawaz; K Dehne; J Köhler; J F Marshall; H Graeff; M Schmitt; U Reuning; E Lengyel
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Role of the beta1-integrin subunit in the adhesion, extravasation and migration of T24 human bladder carcinoma cells.

Authors:  Christoph Heyder; Eva Gloria-Maercker; Wolfgang Hatzmann; Bernd Niggemann; Kurt S Zänker; Thomas Dittmar
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 4.  The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth.

Authors:  S M Ivanchuk; S Mondal; P B Dirks; J T Rutka
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contacts.

Authors:  R Fåhraeus; D P Lane
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

Review 6.  Brain metastases: biology and the role of the brain microenvironment.

Authors:  V K Puduvalli
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

Review 7.  Blastocysts don't go it alone. Extrinsic signals fine-tune the intrinsic developmental program of trophoblast cells.

Authors:  D Randall Armant
Journal:  Dev Biol       Date:  2005-04-15       Impact factor: 3.582

8.  MR imaging of mouse leptomeningeal metastases.

Authors:  Dieta Brandsma; Martin J B Taphoorn; Jaap C Reijneveld; Thomas M Nas; Emile E Voest; Klaas Nicolay; Erwin Blezer
Journal:  J Neurooncol       Date:  2004-06       Impact factor: 4.130

9.  Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progression.

Authors:  Christine Böger; Holger Kalthoff; Simon L Goodman; Hans-Michael Behrens; Christoph Röcken
Journal:  Virchows Arch       Date:  2013-11-26       Impact factor: 4.064

10.  Angiogenic expression profile of normal and neurofibromin-deficient human Schwann cells.

Authors:  Stacey L Thomas; George H De Vries
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 4.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.